Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

Gastroenterology

Volumn 118, Issue 6, 2000, Pages 1025-1030

  Colombel, Jeanfrédéric ^a   Ferrari, Nicolas ^b   Debuysere, Hervé ^a   Marteau, Philippe ^c   Gendre, Jeanpierre ^d   Bonaz, Bruno ^e   Soulé, Jean claude ^f   Modigliani, Robert ^g   Touze, Yvan ^a   Catala, Pascale ^a   Libersa, Christian ^b   Broly, Franck ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b University of Lille   (France)

^c Hopital Laennec   (France)

^d HÔPITAL ROTHSCHILD   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f HÔPITAL LOUIS MOURIER   (France)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; CAPTOPRIL; CORTICOSTEROID; COTRIMOXAZOLE; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; OLSALAZINE; THIOPURINE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CROHN DISEASE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; LEUKOPENIA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0034093057     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70354-4     Document Type: Article

References (37)

1. DH Present SJ Meltzer MP Krumholz A Wolke BI. Korelitz 6-Mercaptopurine in the management of inflammatory bowel disease: short-and long-term toxicity Ann Intern Med 111 1989 641 649
2. WR Connell MA Kamm JK Ritchie JE. Lennard-Jones Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience Gut 34 1993 1081 1085
3. EY Krynetski NF Kr ynetskaia Y Yanishevski WE. Evans Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase Mol Pharmacol 47 1995 1141 1147
4. RM Weinshilboum SL. Sladek Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity Am J Hum Genet 32 1980 651 662
5. L Lennard JA Van Loon JS Lilleyman RM. Weinshilboum Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations Clin Pharmacol Ther 41 1987 18 25
6. L Lennard JS Lilleyman J Van Loon RM. Weinshilboum Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia Lancet 336 1990 225 229
7. E Schutz J Gummert VW Armstrong FW Mohr M. Oellerich Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation Eur J Clin Chem Clin Biochem 34 1996 199 205
8. EY Krynetski JD Schuetz AJ Galpin CH Pui MV Relling WE. Evans A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase Proc Natl Acad Sci U S A 92 1995 949 953
9. D Otterness C Szumlanski RM. Weinshilboum Human thiopurine methyltransferase pharmacogenetics: identification of a novel variant allele (abstr) J Invest Med 44 1996 248A
10. D Otterness C Szumlanski L Lennard B Klemetsdal J Aarbakke JO Park-Hah H Iven K Schmiegelow E Branum J O'Brien R. Weinshilboum Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms Clin Pharmacol Ther 62 1997 60 73
11. D Otterness C Szumlanski T Wood RM. Weinshilboum Human thiopurine methyltransferase pharmacogenetics: kindred with a terminal exon splice junction mutation that results in loss of activity J Clin Invest 101 1998 1036 1044
12. C Szumlanski D Otterness C Her D Lee B Brandriff D Kelsell N Spurr L Lennard E Wieben RM. Weinshilboum Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism DNA Cell Biol 15 1996 17 30
13. HL Tai EY Krynetski CR Yates T Loennechen MY Fessing NF Krynetskaia WE. Evans Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians Am J Hum Genet 58 1996 694 702
14. CR Yates EY Krynetski T Loennechen MY Fessing HL Tai CH Pui MV Relling WE. Evans Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance Ann Intern Med 126 1997 608 614
15. C Spire-Vayron de la Moureyre N Sabbagh D Marez E Vinner ED Chevalier JM Lo Guidice F. Broly Detection of known and new mutations in the thiopurine S-methyltransferase gene by singlestrand conformation polymorphism analysis Hum Mutat 12 1998 177 185
16. T Maniatis J Sambrook EF. Fritsh Commonly used techniques in molecular cloning N Ford C Nolan M Ferguson M Ockler Molecular cloning; a laboratory manual. 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, NY E1 E8
17. C Spire-Vayron de la Moureyre H Debuysere B Mastain E Vinner D Marez JM Lo Guidice D Chevalier S Brique K Motte JF Colombel D Turck C Noel RM Flipo A Pol M Lhermitte JJ Lafitte C Libersa F. Broly Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population Br J Pharmacol 125 1998 879 887
18. T Loennechen CR Yates MY Fessing MV Relling EY Kr ynetski WE. Evans Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans Clin Pharmacol Ther 64 1998 46 51
19. YY Hon MY Fessing CH Pui MV Relling EY Kr ynetski WE. Evans Polymorphism of the thiopurine S-methyltransferase gene in African-Americans Hum Mol Genet 8 1999 371 376
20. MM Ameway ESR Collie-Duguid RH Powrie D Oforie-Adjei HL. McLeod Thiopurine S-methyltransferase alleles in British and Ghanians populations Hum Mol Genet 8 1999 367 370
21. C Cuffari M Picco S Hunt T. Bayless Azathioprine metabolite levels predict clinical responsiveness to therapy in IBD (abstr) Gastroenterology 116 1999 A694
22. MC Dubinsky S Lamothe HY Yang SR Targan D Sinnett Y Theoret EG. Seidman Optimizing and individualizing 6-MP therapy in IBD: the role of 6-MP metabolite levels and TPMT genotyping (abstr) Gastroenterology 116 1999 A702
23. E Schutz J Gummert FW Mohr VW Armstrong M. Oellerich Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine? Ther Drug Monit 18 1996 228 233
24. S Bergan HE Rugstad O Bentdal G Sodal A Hartmann T Leivestad O. Stokke Monitored high-dose azathioprine treatment reduces acute rejection after renal transplantation Transplantation 66 1998 334 339
25. PR Chocair JA Duley HA Simmonds JS. Cameron The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients Transplantation 53 1992 1051 1056
26. PA Pazmino SL Sladek RM. Weinshilboum Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors Clin Pharmacol Ther 28 1980 356 367
27. L. Lennard Clinical implications of thiopurine methyltransferase—optimization of drug dosage and potential drug interactions Ther Drug Monit 20 1998 527 531
28. J Mircheva C Legendre C Soria-Royer E Thervet P Beaune H. Kreis Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients Transplantation 60 1995 639 642
29. JH Feusner SJ Slichter LA. Harker Mechanisms of thrombocytopenia in varicella Am J Hematol 7 1979 255 264
30. AM Kamper M Malbrain P Zachee SL. Chew Parvovirus infection causing red cell aplasia and leukopenia in rheumatoid arthritis Clin Rheumatol 13 1994 129 131
31. S Veraldi G Rizzitelli G Lunghi R. Cardone Primary infection by human parvovirus B19 Dermatology 186 1993 72 74
32. G Venkat Raman VL Sharman HA. Lee Azathioprine and allopurinol: a potentially dangerous combination J Intern Med 228 1990 69 71
33. CL Szumlanski RM. Weinshilboum Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine Br J Clin Pharmacol 39 1995 456 459
34. LD Lewis A Benin CL Szumlanski DM Otterness L Lennard RM Weinshilboum DW. Nierenberg Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drugdrug interaction Clin Pharmacol Ther 62 1997 464 475
35. M Keisu BE Wiholm J. Palmblad Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system J Intern Med 228 1990 353 360
36. JT Groel SS Tadros GR Dreslinski AC. Jenkins Long-term antihypertensive therapy with captopril Hypertension 5 1983 145 151
37. JA. Smith Neutropenia associated with metronidazole therapy (letter) CMAJ 123 1980 202